We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YVR
8001
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$0 ﹤0.01%
+5
New +$121
ATTO
8002
DELISTED
Atento S.A.
ATTO
-232
Closed -$13K
NYMX
8003
PUT
DELISTED
Nymox Pharmaceutical Corp
NYMX
-16,000
Closed -$70K
PSMG
8004
DELISTED
Invesco Growth Multi-Asset Allocation ETF
PSMG
-20
Closed
NVCN
8005
DELISTED
Neovasc Inc.
NVCN
0
-$2K
HOLD
8006
DELISTED
AdvisorShares North Square McKee Core Reserves ETF
HOLD
-60
Closed -$6K
ALR
8007
DELISTED
AlerisLife Inc
ALR
$0 ﹤0.01%
23
-422
-95% -$6.78K
ALBO
8008
DELISTED
Albireo Pharma Inc
ALBO
-1
Closed
IRL
8009
DELISTED
NEW IRELAND FUND INC
IRL
$0 ﹤0.01%
3
-5,237
-100% -$72.4K
RSX
8010
PUT
DELISTED
VanEck Russia ETF
RSX
-500,000
Closed -$9.59M
SMIT
8011
DELISTED
Schmitt Industries Inc
SMIT
$0 ﹤0.01%
133
AGTC
8012
DELISTED
Applied Genetic Technologies Corporation
AGTC
-31,703
Closed -$161K
GBT
8013
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
-5,000
Closed -$137K
ALJJ
8014
DELISTED
ALJ Regional Holdings Inc
ALJJ
$0 ﹤0.01%
92
-200
-68% -$635
DIVA
8015
DELISTED
AGFiQ Hedged Dividend Income Fund
DIVA
-101
Closed -$3K
NDRAW
8016
DELISTED
ENDRA Life Sciences Inc. Warrants
NDRAW
-300
Closed
VOLT
8017
DELISTED
Volt Information Sciences, Inc.
VOLT
-2,572
Closed -$10K
PBCT
8018
CALL
DELISTED
People's United Financial Inc
PBCT
-38,300
Closed -$676K
NSPRZ
8019
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$0 ﹤0.01%
+6,148
New +$524
DSKEW
8020
DELISTED
Daseke, Inc. Warrant
DSKEW
-14,010
Closed -$17K
PAVMW
8021
DELISTED
PAVmed Inc. Warrant
PAVMW
-30
Closed
CETXW
8022
DELISTED
Cemtrex Inc. Series 1 Warrant
CETXW
-127
Closed
JRJC
8023
DELISTED
China Finance Online Co., Ltd.
JRJC
-351
Closed -$6K
PCOM
8024
DELISTED
Points.com Inc. Common Shares
PCOM
-1,949
Closed -$18K
GDP
8025
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$0 ﹤0.01%
1
-164
-99% -$1.75K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.